2025-12-04 - Analysis Report
Okay, here's a comprehensive analysis of Equinix (EQIX) based on the data you provided.

**1. Return Rate Comparison with S&P 500 (VOO)**

*   **EQIX Overview:** Equinix Inc is a global interconnection and data center company.
*   **EQIX Cumulative Return:** 27.69%
*   **VOO Cumulative Return:** 100.36%
*   **Divergence:** -69.8 (Relative divergence: 0.0)

**Analysis:** EQIX has significantly underperformed the S&P 500 (VOO) over the analyzed period. The cumulative return is substantially lower, resulting in a significant divergence. A relative divergence of 0.0 indicates this underperformance is at the lowest end of its historical range compared to VOO.

**Alpha, Beta, CAGR, MDD Analysis:**

| Year       | CAGR  | MDD   | Alpha  | Beta  | Cap(B) |
|------------|-------|-------|--------|-------|--------|
| 2015-2017  | 37.0% | 65.9% | 8.0%   | 0.0   | 44.5   |
| 2016-2018  | -11.0% | 71.8% | -26.0%  | -0.0   | 34.6   |
| 2017-2019  | 17.0% | 71.8% | -5.0%   | -0.2   | 57.3   |
| 2018-2020  | 24.0% | 78.9% | 0.0%   | -0.1   | 70.1   |
| 2019-2021  | 74.0% | 78.9% | 27.0%  | 0.2   | 83.0   |
| 2020-2022  | -4.0% | 79.9% | -3.0%   | 1.4   | 64.3   |
| 2021-2023  | -22.0% | 80.2% | -23.0%  | 2.0   | 79.1   |
| 2022-2024  | -6.0% | 80.2% | -26.0%  | 2.1   | 92.6   |
| 2023-2025  | -12.0% | 81.7% | -77.0%  | 1.1   | 71.6   |

*   **CAGR:** The Compounded Annual Growth Rate shows strong growth in some periods (e.g., 2019-2021) but significant declines in others (e.g., 2021-2023). More recently, the CAGR has been negative.
*   **MDD:** The Maximum Drawdown indicates significant potential loss from peak to trough over each period. MDD has generally increased indicating greater risk.
*   **Alpha:** Alpha measures the stock's performance relative to its beta. A negative Alpha in recent years indicates underperformance relative to its risk.
*   **Beta:** Beta measures the stock's volatility relative to the market. Beta values have been rising.
*   **Cap(B):** Shows the market capitalization in billions.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** 728.94
*   **Last Market Data:** Price: 729.605, Previous Close: 727.38, Change: 0.31
*   **5-day SMA:** 741.994
*   **20-day SMA:** 781.2287
*   **60-day SMA:** 794.3996

**Analysis:** The current price is below all the Simple Moving Averages (SMAs), indicating a potential downtrend. The short-term (5-day) SMA is closest to the current price, but still above it, while the 60-day SMA is significantly higher. The last market data change is slightly positive.

**3. Indicator Analysis**

*   **MRI (Market Risk Indicator):** 0.9 (High Investment Recommended)
*   **RSI (Relative Strength Index):** 12.44 (Oversold)
*   **PPO (Percentage Price Oscillator):** -0.7561
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (2 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00)
*   **Recent Relative Divergence Change (20 days):** -4.0 (Short-term decline)
*   **Expected Return (%):** -1745.7

**Analysis:**
*   The MRI suggests a high investment recommendation, which contradicts most other indicators. This might be due to specific models used to compute MRI that is not clear from provided information.
*   The RSI indicates the stock is heavily oversold, which *could* suggest a potential for a rebound.
*   The PPO is negative, confirming the downtrend.
*   The Hybrid Signal suggests a "Buy" recommendation and continuous investment with monthly investment allocation, considering it very safe based on MRI 0.9.
*   The significant negative expected return is a major red flag, forecasting a large potential loss if invested long-term.
*   The recent divergence change indicates a short-term decline.

**4. Recent News & Significant Events**

*   **Positive Analyst Updates:** Several articles mention positive analyst ratings, including an upgrade to "Outperform" by BMO Capital and a $900 price target from Quiver Quantitative.
*   **SEC Probe End:** News reports the end of an SEC probe, which can be a positive catalyst.
*   **AI Supercomputer Deal:** Mention of an AI Supercomputer deal could signal future growth opportunities.
*   **Wall Street Positive Sentiment:** Articles indicate positive sentiment from Wall Street analysts.
*   **"Safe Investment" Questioned:** One headline asks whether EQIX is a safe investment, implying some uncertainty.

**Analysis:** Recent news is mixed. Analyst upgrades and the end of the SEC probe are positive, while the question of safety suggests underlying concerns. It's important to critically evaluate analyst opinions, as they can be lagging indicators.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (~1.66 on a 1-5 scale)
*   **Target Price:** Average: $965.28, High: $1200.00, Low: $804.00

**Analysis:** The analyst consensus is "Buy" with a significant average target price above the current price. However, consider the range of target prices; the low end is closer to the current price.

**5. Recent Earnings Analysis**

| 날짜         | EPS  | 매출     |
|--------------|------|----------|
| 2025-10-29   | 3.82 | 2.32 B$  |
| 2025-07-30   | 3.76 | 2.26 B$  |
| 2025-04-30   | 3.52 | 2.23 B$  |
| 2024-10-30   | 3.11 | 2.20 B$  |
| 2025-10-29   | 3.11 | 2.20 B$  |

**Analysis:** EPS and revenue have generally been increasing quarter-over-quarter, which is a positive sign. The most recent EPS is 3.82 and revenue is 2.32B.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $2.32B    | 50.69%        |
| 2025-06-30   | $2.26B    | 51.95%        |
| 2025-03-31   | $2.23B    | 51.28%        |
| 2024-12-31   | $2.26B    | 47.10%        |
| 2024-09-30   | $2.20B    | 50.11%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
|--------------|-----------|----------|
| 2025-09-30   | $14.16B   | 2.64%    |
| 2025-06-30   | $14.08B   | 2.61%    |
| 2025-03-31   | $13.89B   | 2.47%    |
| 2024-12-31   | $13.53B   | -0.10%   |
| 2024-09-30   | $13.59B   | 2.19%    |

**Analysis:**

*   **Revenue:** Revenue has been generally increasing, indicating growth.
*   **Profit Margin:** Profit margins are healthy and relatively stable.
*   **Equity:** Equity is also generally increasing, showing a growing asset base.
*   **ROE:** Return on Equity is positive, indicating profitability, however, it fluctuates. The ROE had a negative dip in 2024-12-31.

**7. Comprehensive Analysis**

**Summary:**

*   **Underperformance:** EQIX has significantly underperformed the S&P 500 recently.
*   **Downtrend:** The stock is currently in a downtrend, trading below its moving averages.
*   **Oversold:** The RSI suggests the stock is oversold and *could* be due for a rebound.
*   **Negative Outlook:** The negative expected return is a major concern.
*   **Mixed Signals:** Analyst ratings are generally positive, but recent news headlines question the stock's safety as an investment.
*   **Financial Health:** Revenue, Profit Margin, and Equity are increasing.
*   **Unclear MRI:** The MRI indicator recommends high investment while other indicators disagree.

**Overall Recommendation (Caution Advised):**

While there are some positive aspects (analyst ratings, recent earnings, revenue growth, oversold RSI), the significant underperformance compared to the S&P 500, the downtrend, the negative expected return, and the questioned safety suggest caution.

**Before investing, consider the following:**

*   **Reasons for Underperformance:** Understand *why* EQIX has been underperforming. Is it a sector-specific issue, company-specific problems, or broader market factors?
*   **Sustainability of Growth:** Can the revenue growth and healthy profit margins be sustained?
*   **Debt Levels:** Analyze the company's debt levels and ability to service its debt. (This data was not provided.)
*   **External Factors:** Consider broader economic conditions and industry trends that could impact EQIX.
*   **Risk Tolerance:** Make sure this investment aligns with your risk tolerance, especially considering the recent volatility and negative expected return.

**Disclaimer:** This is an analysis based on the provided data and should not be considered financial advice. Consult with a qualified financial advisor before making any investment decisions.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.